Literature DB >> 19200802

Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells.

Tim C P Somervaille1, Christina J Matheny, Gary J Spencer, Masayuki Iwasaki, John L Rinn, Daniela M Witten, Howard Y Chang, Sheila A Shurtleff, James R Downing, Michael L Cleary.   

Abstract

The genetic programs that promote retention of self-renewing leukemia stem cells (LSCs) at the apex of cellular hierarchies in acute myeloid leukemia (AML) are not known. In a mouse model of human AML, LSCs exhibit variable frequencies that correlate with the initiating MLL oncogene and are maintained in a self-renewing state by a transcriptional subprogram more akin to that of embryonic stem cells (ESCs) than to that of adult stem cells. The transcription/chromatin regulatory factors Myb, Hmgb3, and Cbx5 are critical components of the program and suffice for Hoxa/Meis-independent immortalization of myeloid progenitors when coexpressed, establishing the cooperative and essential role of an ESC-like LSC maintenance program ancillary to the leukemia-initiating MLL/Hox/Meis program. Enriched expression of LSC maintenance and ESC-like program genes in normal myeloid progenitors and poor-prognosis human malignancies links the frequency of aberrantly self-renewing progenitor-like cancer stem cells (CSCs) to prognosis in human cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200802      PMCID: PMC2670853          DOI: 10.1016/j.stem.2008.11.015

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  40 in total

1.  Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.

Authors:  Chi Wai So; Min Lin; Paul M Ayton; Everett H Chen; Michael L Cleary
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

2.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.

Authors:  Paul M Ayton; Michael L Cleary
Journal:  Genes Dev       Date:  2003-09-02       Impact factor: 11.361

3.  MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.

Authors:  Chi Wai So; Holger Karsunky; Emmanuelle Passegué; Antonio Cozzio; Irving L Weissman; Michael L Cleary
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

4.  Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia.

Authors:  E R Fearon; P J Burke; C A Schiffer; B A Zehnbauer; B Vogelstein
Journal:  N Engl J Med       Date:  1986-07-03       Impact factor: 91.245

5.  Colony assay for proliferative blast cells circulating in myeloblastic leukaemia.

Authors:  R N Buick; J E Till; E A McCulloch
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

6.  Identification of a gene expression signature associated with pediatric AML prognosis.

Authors:  Tomohito Yagi; Akira Morimoto; Mariko Eguchi; Shigeyoshi Hibi; Masahiro Sako; Eiichi Ishii; Shuki Mizutani; Shinsaku Imashuku; Misao Ohki; Hitoshi Ichikawa
Journal:  Blood       Date:  2003-05-08       Impact factor: 22.113

7.  Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.

Authors:  Chi Wai So; Holger Karsunky; Piu Wong; Irving L Weissman; Michael L Cleary
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

8.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

Review 9.  Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

Authors:  Emmanuelle Passegué; Catriona H M Jamieson; Laurie E Ailles; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

10.  AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

Authors:  Daniel J Pearce; David Taussig; Kazem Zibara; Lan-Lan Smith; Christopher M Ridler; Claude Preudhomme; Bryan D Young; Ama Z Rohatiner; T Andrew Lister; Dominique Bonnet
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

View more
  177 in total

1.  Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.

Authors:  Juraj Bies; Marek Sramko; Joanna Fares; Michael Rosu-Myles; Steven Zhang; Richard Koller; Linda Wolff
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

2.  Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?

Authors:  Tim C P Somervaille; Michael L Cleary
Journal:  Int J Hematol       Date:  2010-05-08       Impact factor: 2.490

Review 3.  Cancer stem cells: a stride towards cancer cure?

Authors:  Amitava Sengupta; Jose A Cancelas
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

4.  Meis1 maintains stemness signature in MLL-AF9 leukemia.

Authors:  Ashish R Kumar; Aaron L Sarver; Baolin Wu; John H Kersey
Journal:  Blood       Date:  2010-04-29       Impact factor: 22.113

5.  Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states.

Authors:  Arvind Shakya; Jinsuk Kang; Jeffrey Chumley; Matthew A Williams; Dean Tantin
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

Review 6.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

7.  Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.

Authors:  J M Heddleston; Q Wu; M Rivera; S Minhas; J D Lathia; A E Sloan; O Iliopoulos; A B Hjelmeland; J N Rich
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

8.  An isoform-specific C/EBPβ inhibitor targets acute myeloid leukemia cells.

Authors:  A Jakobs; S Uttarkar; C Schomburg; S Steinmann; A Coulibaly; P Schlenke; W E Berdel; C Müller-Tidow; T J Schmidt; K-H Klempnauer
Journal:  Leukemia       Date:  2016-02-08       Impact factor: 11.528

9.  CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.

Authors:  Masayuki Iwasaki; Michaela Liedtke; Andrew J Gentles; Michael L Cleary
Journal:  Cell Stem Cell       Date:  2015-09-18       Impact factor: 24.633

10.  High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.

Authors:  Hua-Rong Tang; Xian-Qin Luo; Gang Xu; Yan Wang; Zhi-Jun Feng; Hui Xu; Ya-Wei Shi; Qin Zhang; Li-Guang Wu; Chun-Quan Xue; Cheng-Wei Wang; Chao-Yang Wu
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.